Determining cost and placement decisions for moderate complexity NAATs for tuberculosis drug susceptibility testing

Determining cost and placement decisions for moderate complexity NAATs for tuberculosis drug susceptibility testing

Show other versions (1)

<h4>Background</h4> Access to drug resistant testing for tuberculosis (TB) remains a challenge in high burden countries. Recently, the World Health Organization approved the use of several moderate complexity automated nucleic acid amplification tests (MC-NAAT) that have performance prof...

Full description

Bibliographic Details
Main Authors: Akash Malhotra, Ryan Thompson, Margaretha De Vos, Anura David, Samuel Schumacher, Hojoon Sohn
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2023-01-01
Series:PLoS ONE
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10449112/?tool=EBI

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10449112/?tool=EBI

Similar Items